DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹8,923 Cr | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr |
What is the latest Total Non-Current Assets ratio of DIVIS LABORATORIES ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹8,923 Cr |
| Mar2025 | ₹6,840 Cr |
| Mar2024 | ₹5,785 Cr |
| Mar2023 | ₹5,113 Cr |
| Mar2022 | ₹5,009 Cr |
How is Total Non-Current Assets of DIVIS LABORATORIES Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,923 Cr | 30.45 | |
| Mar2025 | ₹6,840 Cr | 18.24 | |
| Mar2024 | ₹5,785 Cr | 13.14 | |
| Mar2023 | ₹5,113 Cr | 2.08 | |
| Mar2022 | ₹5,009 Cr | - | |
Compare Total Non-Current Assets of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹208,165.3 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| MANKIND PHARMA | ₹106,427.0 Cr | 1.4% | 1.8% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 6.7% |
18.5% |
12.2% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses